Conexeu Sciences Income Statement

Financials in millions USD. Fiscal year is November - October.

Millions USD. Fiscal year is Nov - Oct.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Oct '25 Oct 31, 2025	Oct '24 Oct 31, 2024	Oct '23 Oct 31, 2023
Selling, General & Admin	3.67	0.41	0.04
Depreciation & Amortization Expenses	0.02	-	-
Research & Development	0.27	0.24	-
Total Operating Expenses	3.96	0.64	0.04
Operating Income	-3.96	-0.64	-0.04
Interest Income	0	-	-
Interest Expense	-0	-0.02	-
Other Non-Operating Income (Expense)	0.04	0.19	0
Total Non-Operating Income (Expense)	0.04	0.17	0
Pretax Income	-3.92	-0.47	-0.04
Net Income	-3.92	-0.47	-0.04
Net Income to Common	-3.92	-0.47	-0.04
Shares Outstanding (Basic)	13	7	2
Shares Outstanding (Diluted)	13	7	2
Shares Change (YoY)	87.74%	286.25%	-
EPS (Basic)	-0.31	-0.07	-0.02
EPS (Diluted)	-0.31	-0.07	-0.02
Shares Outstanding	18.91	8.53	4.16
EBIT	-3.96	-0.64	-0.04

Updated Apr 17, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q